1-20 of 109
Wei Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer

Junghui Koo, Chang-Soo Seong, Rebecca E. Parker, Amy Herrera, Bhakti Dwivedi, Robert A. Arthur, Ashok Reddy. Dinasarapu, H. Richard. Johnston, Henry Claussen, Carol Tucker-Burden, Suresh S. Ramalingam, Haian Fu, Wei Zhou, Adam I. Marcus, Melissa Gilbert-Ross
Journal: Cancer Research
Cancer Res (2024)
https://doi.org/10.1158/0008-5472.CAN-23-2631
Published: 29 August 2024
View article titled, Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Open the PDF for Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract 4047: Unraveling synergistic therapeutic strategies involving FAK inhibition and immunotherapy using anti-PD1 antibody in KRAS and LKB1-driven lung cancer

Junghui Koo, Carol Tucker-Burden, Melissa Roy, Chunzi Huang, Wei Zhou, Melissa Gilbert-Ross, Haian Fu, Suresh S. Ramalingam, Adam I. Marcus
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4047.
https://doi.org/10.1158/1538-7445.AM2024-4047
Published: 22 March 2024
View article titled, Abstract 4047: Unraveling synergistic therapeutic strategies involving FAK inhibition and immunotherapy using anti-PD1 antibody in KRAS and LKB1-driven lung cancer
Journal Articles

Foretinib Is Effective in Acute Myeloid Leukemia by Inhibiting FLT3 and Overcoming Secondary Mutations That Drive Resistance to Quizartinib and Gilteritinib

Peihong Wang, Yvyin Zhang, Rufang Xiang, Jie Yang, Yanli Xu, Tingfen Deng, Wei Zhou, Caixia Wang, Xinhua Xiao, Shunqing Wang
Journal: Cancer Research
Cancer Res (2024) 84 (6): 905–918.
https://doi.org/10.1158/0008-5472.CAN-23-1534
Published: 15 March 2024
View article titled, Foretinib Is Effective in Acute Myeloid Leukemia by Inhibiting FLT3 and Overcoming Secondary Mutations That Drive Resistance to Quizartinib and Gilteritinib
Open the PDF for Foretinib Is Effective in Acute Myeloid Leukemia by Inhibiting FLT3 and Overcoming Secondary Mutations That Drive Resistance to Quizartinib and Gilteritinib in another window
Includes: Supplementary data
Journal Articles

Abstract A005: Alanine metabolism is an ARID1A-dependent vulnerability in clear cell ovarian carcinoma

Hao Nie, Wei Zhou, Chen Wang, Nan Zhang, Shuai Wu, Rugang Zhang
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): A005.
https://doi.org/10.1158/1538-7445.OVARIAN23-A005
Published: 04 March 2024
View article titled, Abstract A005: Alanine metabolism is an ARID1A-dependent vulnerability in clear cell ovarian carcinoma
Journal Articles

Abstract B029: Targeting non-canonical function of TXNRD1 to overcome platinum resistance by eradicating ovarian cancer stem-like cells

Martina Towers, Xue Hao, Shruthi Sriramkumar, Wei Zhou, Rugang Zhang
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): B029.
https://doi.org/10.1158/1538-7445.OVARIAN23-B029
Published: 04 March 2024
View article titled, Abstract B029: Targeting non-canonical function of TXNRD1 to overcome platinum resistance by eradicating ovarian cancer stem-like cells
Journal Articles

Abstract B076: Targeting cancer glycomes sensitizes ovarian tumors to immunotherapy

Hao Nie, Pratima Saini, Heng Liu, Wei Zhou, Chen Wang, Daniel Claiborne, Nan Zhang, Mohamed Abdel-Mohsen, Rugang Zhang
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): B076.
https://doi.org/10.1158/1538-7445.OVARIAN23-B076
Published: 04 March 2024
View article titled, Abstract B076: Targeting cancer glycomes sensitizes ovarian tumors to immunotherapy
Journal Articles

Fimepinostat Impairs NF­κB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma

Dan Wang, Kun Yan, Hongxing Yu, Haocheng Li, Wei Zhou, Yaqiang Hong, Shuning Guo, Yi Wang, Cheng Xu, Changcun Pan, Yujie Tang, Nian Liu, Wei Wu, Liwei Zhang, Qiaoran Xi
Journal: Cancer Research
Cancer Res (2024) 84 (4): 598–615.
https://doi.org/10.1158/0008-5472.CAN-23-0394
Published: 15 February 2024
View article titled, Fimepinostat Impairs NF­κB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma
Open the PDF for Fimepinostat Impairs NF­κB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma in another window
Includes: Supplementary data
Journal Articles

Abstract 1871: Novel conditionally active bispecific HER2 x CD3 T cell engager targeting solid tumors

Ana Paula Cugnetti, Haizhen Liu, Patricia McNeeley, Christina Wheeler, Matthew Lucas, Charles Xing, Solmarie Joyner, Kyrie Johnson, Kathryn Woodard, Wei Zhou, Cathy Chang, Gerhard Frey, William J. Boyle, Jay M. Short
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1871.
https://doi.org/10.1158/1538-7445.AM2023-1871
Published: 04 April 2023
View article titled, Abstract 1871: Novel conditionally active bispecific HER2 x CD3 T cell engager targeting solid tumors
Journal Articles

Abstract 811: Development of a NOX-ROS nanoinhibitor for enhancing response to radiotherapy in lung cancer cells while mitigation radiation-induced inflammation and injury in the normal lung tissue

Lei Zhu, Lumeng Zhang, Tongrui Liu, Wei Ping Qian, Wei Zhou, Lily Yang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 811.
https://doi.org/10.1158/1538-7445.AM2023-811
Published: 04 April 2023
View article titled, Abstract 811: Development of a NOX-ROS nanoinhibitor for enhancing response to radiotherapy in lung cancer cells while mitigation radiation-induced inflammation and injury in the normal lung tissue
Journal Articles

Abstract 6335: Developing anti-IL-22 therapeutics for inflammation and cancer

Christina Wheeler, Jian Chen, Cathy Chang, Gerhard Frey, Haizhen Liu, Jing Wang, Kathryn Woodard, Solmarie Joyner, Wei Zhou, William J. Boyle, Jay M. Short
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6335.
https://doi.org/10.1158/1538-7445.AM2023-6335
Published: 04 April 2023
View article titled, Abstract 6335: Developing anti-IL-22 therapeutics for inflammation and cancer
Journal Articles

Abstract 1879: A novel dual CAB nectin-4 x CD3 bispecific antibody targeting solid tumors

Matthew Lucas, Ana Paula Cugnetti, Haizhen Liu, Charles Xing, Jing Wang, Patricia McNeeley, Christina Wheeler, Solmarie Joyner, Kyrie Johnson, Kathryn Woodard, Wei Zhou, Cathy Chang, Gerhard Frey, William J. Boyle, Jay M. Short
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1879.
https://doi.org/10.1158/1538-7445.AM2023-1879
Published: 04 April 2023
View article titled, Abstract 1879: A novel dual CAB nectin-4 x CD3 bispecific antibody targeting solid tumors
Journal Articles

Abstract 16: The role of innate and adaptive immunity in the sex bias of LKB1-mutant lung adenocarcinoma

Yijian Fan, Lenore Monterroza, Rui Jin, Xiuju Liu, Periasamy Selvaraj, Rabindra Tirouvanziam, Wei Zhou
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 16.
https://doi.org/10.1158/1538-7445.AM2023-16
Published: 04 April 2023
View article titled, Abstract 16: The role of innate and adaptive immunity in the sex bias of LKB1-mutant lung adenocarcinoma
Journal Articles

Abstract P2-24-04: The ER antagonist giredestrant induces profound chromatin remodeling including activation of cis-regulatory elements bound by FOXA1 and GATA3 in HR+ breast cancer models

Musaddeque Ahmed, Jane Guan, Wei Zhou, Xiaosai Yao, Ciara Metcalfe, Marc Hafner
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P2-24-04.
https://doi.org/10.1158/1538-7445.SABCS22-P2-24-04
Published: 01 March 2023
View article titled, Abstract P2-24-04: The ER antagonist giredestrant induces profound chromatin remodeling including activation of cis-regulatory elements bound by FOXA1 and GATA3 in HR+ breast cancer models
Journal Articles

Abstract 5388: Triple-threat: Inavolisib and giredestrant combine with palbociclib to achieve sustained cell cycle arrest in ER-positive breast cancer models

Taylor Marohl, Jenille Tan, Wei Zhou, Jane Guan, Sandra Melo Carlos, Shiqi Xie, Marc Hafner, Ciara Metcalfe
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5388.
https://doi.org/10.1158/1538-7445.AM2022-5388
Published: 15 June 2022
View article titled, Abstract 5388: Triple-threat: Inavolisib and giredestrant combine with palbociclib to achieve sustained cell cycle arrest in ER-positive breast cancer models
Journal Articles

Abstract 936: Developing a sex-biased model for LKB1-mutant lung adenocarcinoma

Yijian Fan, Rui Jin, Xiuju Liu, Yuan Liu, Chunzi Huang, Mellissa Gilbert-Ross, Adam Marcus, Wei Zhou
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 936.
https://doi.org/10.1158/1538-7445.AM2022-936
Published: 15 June 2022
View article titled, Abstract 936: Developing a sex-biased model for LKB1-mutant lung adenocarcinoma
Journal Articles

Abstract 419: Presence of pulmonary tuberculosis impair survival in advanced EGFR mutation lung adenocarcinoma patients receiving epidermal growth factor receptor-tyrosine kinase inhibitor

Yalin Xie, Wei Zhou, An Lei, Zhan Huang, Li Weiwei, Changbin Zhu, Guanshan Zhu, Wenchang Cen
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 419.
https://doi.org/10.1158/1538-7445.AM2021-419
Published: 01 July 2021
View article titled, Abstract 419: Presence of pulmonary tuberculosis impair survival in advanced <em>EGFR</em> mutation lung adenocarcinoma patients receiving epidermal growth factor receptor-tyrosine kinase inhibitor
Journal Articles

KRASQ61H Preferentially Signals through MAPK in a RAF Dimer-Dependent Manner in Non–Small Cell Lung Cancer

Zhi-Wei Zhou, Chiara Ambrogio, Asim K. Bera, Qing Li, Xing-Xiao Li, Lianbo Li, Jieun Son, Sudershan Gondi, Jiaqi Li, Emily Campbell, Hua Jin, Jeffrey J. Okoro, Cheng-Xiong Xu, Pasi A. Janne, Kenneth D. Westover
Journal: Cancer Research
Series: Author Choice
Cancer Res (2020) 80 (17): 3719–3731.
https://doi.org/10.1158/0008-5472.CAN-20-0448
Published: 02 September 2020
View article titled, KRAS<sup>Q61H</sup> Preferentially Signals through MAPK in a RAF Dimer-Dependent Manner in Non–Small Cell Lung Cancer
Open the PDF for KRAS<sup>Q61H</sup> Preferentially Signals through MAPK in a RAF Dimer-Dependent Manner in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 3406: GDC-9545: A pure antiestrogen clinical candidate that immobilizes the estrogen receptor and profoundly alters chromatin accessibility in vivo

Ciara Metcalfe, Wei Zhou, Jane Guan, Robert A. Blake, Tom De Bruyn, Jennifer M. Giltnane, Ellen Ingalla, Tracy Kleinheinz, Jun Liang, Vidhi Mody, Jason Oeh, Savita Ubhayakar, Ingrid Wertz, Amy Young, Jason Zbieg, Xiaojing Wang, Marc Hafner
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3406.
https://doi.org/10.1158/1538-7445.AM2020-3406
Published: 15 August 2020
View article titled, Abstract 3406: GDC-9545: A pure antiestrogen clinical candidate that immobilizes the estrogen receptor and profoundly alters chromatin accessibility <em>in vivo</em>
Journal Articles

Abstract 1563: Prediction of immune-checkpoint blockade response in gastrointestinal cancer patients using a machine learning-based RNA signature

Lin Shen, Henghui Zhang, Zhihao Lu, Huan Chen, Xi Jiao, Wei Zhou, Shuang Li, Ying Yang, Dandan Liang
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1563.
https://doi.org/10.1158/1538-7445.AM2020-1563
Published: 15 August 2020
View article titled, Abstract 1563: Prediction of immune-checkpoint blockade response in gastrointestinal cancer patients using a machine learning-based RNA signature
Journal Articles

Abstract P2-11-05: ER pathway activity signature as a biomarker for endocrine agent GDC-9545

Anneleen Daemen, Jill M Spoerke, Wei Zhou, Jane Guan, Ellen Ingalla, Amy Young, Marc Hafner, Junko Aimi, Ching-Wei Chang, Jennifer M Giltnane, Mary Gates, Ingrid A Mayer, Analia Azaro, Eric P Winer, Sherene Loi, Komal Jhaveri, Jennifer Lauchle, Steven Gendreau, Eric W Humke, Ciara Metcalfe
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P2-11-05.
https://doi.org/10.1158/1538-7445.SABCS19-P2-11-05
Published: 15 February 2020
View article titled, Abstract P2-11-05: ER pathway activity signature as a biomarker for endocrine agent GDC-9545